<i>In vivo</i> dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer.
Ontology highlight
ABSTRACT: Lung cancer patients are at risk for brain metastases and often succumb to their intracranial disease. Chimeric Antigen Receptor (CAR) T-cells emerged as a powerful cell-based immunotherapy for hematological malignancies; however, it remains unclear whether CAR T-cells represent a viable therapy for brain metastases. Here, we established a syngeneic orthotopic cerebral metastasis model in mice by combining a chronic cranial window with repetitive intracerebral two-photon laser scanning-microscopy. This approach enabled in vivo-characterization of fluorescent CAR T-cells and tumor cells on a single-cell level over weeks. Intraparenchymal injection of Lewis lung carcinoma cells (expressing the tumor cell-antigen EpCAM) was performed, and EpCAM-directed CAR T-cells were injected either
SUBMITTER: Xu T
PROVIDER: S-EPMC9851202 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
ACCESS DATA